Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm

Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7
Recruiting: 5
Ph III recruiting: 3
Growth YoY: —
Industry share: 0%
Top sponsor: ARCAGY/ GINECO GROUP
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05156268	A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma	completed	Phase 2	26	Memorial Sloan Kettering Cancer CenterOTHER	1	Apr 27, 2026	clinicaltrials
NCT01935934	Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer	completed	Phase 2	102	National Cancer Institute (NCI)NIH	2	Oct 1, 2025	clinicaltrials